← Leaderboards
Hokyung Kay Chung
Salk Institute For Biological Studies
$479,520
Attributed
$479,520
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $159.8K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$479,520 · 1
By mechanism
K01$479,520 · 1
Top collaborators
No co-investigators on record.
Most similar at Salk Institute For Biological Studies
Same institution · by research overlap
- Reuben J Shaw$29,207,114
- Ronald M. Evans$57,364,689
Others in their field
Other Rising Stars on “Adoptive Cell Transfers”
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
- Torben Schiffner · Vanderbilt University$3,383,634
- Amy M Moskop · Medical College Of Wisconsin$3,357,500
- Bozena Korczak · Vascular Vision Pharmaceuticals Company$3,058,782
- Nathan Schuldt · University Of Minnesota$2,999,774
Research focus
Adoptive Cell TransfersAntigensAntitumor ResponseAtlasesAutomobile DrivingBindingBioinformaticsCancer CellCancer TherapyCd8-Positive T-LymphocytesCell MembraneCell ReprogrammingCellsChimeric Antigen Receptor T CellsClinically RelevantCodeCombinatorialCombinatoricsCytotoxicDesignDisease RemissionDoctor Of PhilosophyEffectivenessAdopted
Grant awards (3)
Next-generation T cell therapy: SMARTER T cells for enhanced and durable anti-tumor immunity$159,840
K01 · FY2025 · EB · contact PI
Next-generation T cell therapy: SMARTER T cells for enhanced and durable anti-tumor immunity$159,840
K01 · FY2024 · EB · contact PI
Next-generation T cell therapy: SMARTER T cells for enhanced and durable anti-tumor immunity$159,840
K01 · FY2023 · EB · contact PI